ALLR - Allarity Therapeutics Inc
1.27
0.030 2.362%
Share volume: 178,188
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.24
0.03
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-05-2024 | 11-14-2024 | 05-09-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | |||
| Operating expenses | 4.240 M | 3.371 M | 2.610 M | 3.036 M | 2.518 M | |
| Selling general and admin | 2.070 M | 2.313 M | 1.589 M | 1.633 M | 1.315 M | |
| Research and development | 2.170 M | 1.058 M | 1.021 M | 1.403 M | 1.203 M | |
| Total expenses | 4.240 M | 3.371 M | 12.313 M | 3.036 M | 2.518 M | |
| -20.50% | 265.26% | -75.34% | -17.06% | |||
| Operating income | -4.240 M | -3.371 M | -12.313 M | -3.036 M | -2.518 M | |
| Ebit | -3.745 M | -1.256 M | -12.178 M | -2.897 M | -2.936 M | |
| Pretax income | -3.847 M | -1.629 M | -11.967 M | -2.732 M | -2.806 M | |
| -57.66% | 634.62% | -77.17% | 2.71% | |||
| Income tax | -4.000 K | 0.000 | -377.000 K | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.843 M | -1.629 M | -11.590 M | -2.732 M | -2.806 M | |
| 57.61% | -611.48% | 76.43% | -2.71% |